Scleroderma Patient-centered Intervention Network (SPIN) Hand Program Feasibility Study
NCT03092024 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40
Last updated 2021-07-28
Summary
The Scleroderma Patient-centered Intervention Network (SPIN) is an organization established by researchers, health care providers, and people living with scleroderma from Canada, the USA, and Europe. The objectives of SPIN are (1) to assemble a large cohort of scleroderma patients to complete outcome assessments regularly in order to learn more about important problems faced by people living with scleroderma and (2) to develop and test a series of internet-based interventions to help patients manage aspects of scleroderma, including hand limitations.
In the SPIN-HAND feasibility trial, SPIN Cohort participants with at least mild hand function limitations and an indicated interest in using an online hand exercise program will be randomized to be offered the SPIN hand exercise program or to usual care only. The core SPIN hand exercise program consists of 4 modules that address specific aspects of hand function, including Thumb Flexibility and Strength; Finger Bending; Finger Extension; and Wrist Flexibility and Strength. The program also integrates tools to support key components of successful self-management programs, including goal-setting.
The aim of the SPIN-HAND feasibility study is to collect data to assess the feasibility of the steps that need to take place as part of the main trial; required resources; and scientific aspects (e.g., withdrawal rate, outcomes measures). Data will be used to determine whether it is feasible to carry out the main study or whether changes need to be made before conducting a full-scale RCT of the SPIN-HAND program.
Conditions
- Scleroderma
- Systemic Sclerosis
Interventions
- OTHER
-
SPIN-HAND program
The internet-based SPIN-HAND program consists of 4 modules (1) Thumb Flexibility and Strength (3 exercises); (2) Finger Bending (3 exercises); (3) Finger Extension (3 exercises); and (4) Wrist Flexibility and Strength (2 exercises). The program includes sections on developing a personalized program, goal-setting strategies and examples, progress tracking, sharing goals and progress with friends and family, and patient stories of experiences with hand disability and hand exercises. Instructional videos demonstrate and explain how to perform each exercise properly with pictures to illustrate common mistakes. Separate versions of each exercise are available for patients with mild/moderate and more severe hand involvement.
Sponsors & Collaborators
-
Hôpital Cochin
collaborator OTHER -
Lady Davis Institute
lead OTHER
Principal Investigators
-
Luc Mouthon, MD, PhD · Hôpital Cochin, Paris, France
-
Serge Poiraudeau, MD, PhD · Hôpital Cochin, Paris, France
-
Brett Thombs, PhD · Lady Davis Institute, Montreal, Quebec, Canada
Study Design
- Allocation
- RANDOMIZED
- Purpose
- SUPPORTIVE_CARE
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-06-01
- Primary Completion
- 2017-10-17
- Completion
- 2017-10-17
Countries
- Canada
Study Locations
More Related Trials
-
Evaluating Tools to Communicate Scleroderma Research Results to Patients - Trial #1
NCT06373263 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Taking Charge of Systemic Sclerosis
NCT02494401 ·Status: COMPLETED ·Phase: NA
-
Scleroderma: Functional Disability Between the Dominant and Contralateral Hand.
NCT05171114 ·Status: COMPLETED ·Phase: NA
-
Self-management Telehealth Program for Scleroderma
NCT06990386 ·Status: COMPLETED ·Phase: NA
-
6-minute Pegboard Ring Test in Patients with Scleroderma
NCT06588959 ·Status: NOT_YET_RECRUITING
-
Laser Speckle Contrast Imaging for Cutaneous Microvascular Dysfunction Detection in Systemic Sclerosis.
NCT01743612 ·Status: COMPLETED ·Phase: NA
-
Hand Function Impairment in Systemic Sclerosis: Outcomes, Mechanisms and Experience (HANDSOME)
NCT06133244 ·Status: RECRUITING
-
Improvement of Hand Dysfunction by Arthritis in Systemic Sclerosis
NCT01834157 ·Status: UNKNOWN
-
The Effects of Exercise in Patients With Systemic Sclerosis
NCT03058887 ·Status: COMPLETED ·Phase: NA
-
Effects of a Personalized Standardized Rehabilitation Program in Systemic Sclerosis
NCT00318188 ·Status: COMPLETED ·Phase: NA
-
Exercise in People With Systemic Sclerosis
NCT05234671 ·Status: COMPLETED ·Phase: NA
-
Exercise With Scleroderma Functional Outcomes
NCT06425653 ·Status: COMPLETED ·Phase: NA
-
Medico-economic and Quality of Life Impact of Sjogren-associated Small Fiber Neuropathy
NCT03509064 ·Status: RECRUITING
-
RENEW Scleroderma: A Peer-Mentored, Web Intervention for Resilience-based, Energy Management to Enhance Wellbeing and Fatigue
NCT04908943 ·Status: COMPLETED ·Phase: NA
-
Feasibility and Preliminary Effects of the Resilience-based, Energy Management to Enhance Wellbeing in Systemic Sclerosis (RENEW) Intervention
NCT04588714 ·Status: COMPLETED ·Phase: NA
-
Study of the Efficacy of Nintedanib+Tocilizumab in Patients With Systemic Sclerosis and Interstitial Lung Disease
NCT06297096 ·Status: RECRUITING ·Phase: PHASE3
-
Evaluation of Aesthetic Impact in Patients With Systemic Sclerosis
NCT03271320 ·Status: COMPLETED
-
Effectiveness of a Home-based, Self-administered Exercise Program for Hands in Patients With Systemic Sclerosis
NCT04481984 ·Status: COMPLETED ·Phase: NA
-
Efficacy of a Personalized Rehabilitation Program of Facial Involvement in Systemic Sclerosis
NCT05177380 ·Status: UNKNOWN ·Phase: NA
-
Online Fatigue Intervention Program for People With Scleroderma
NCT04401943 ·Status: COMPLETED ·Phase: NA
-
Treatment and Prevention of Progression of Interstitial Lung Disease in Systemic Sclerosis
NCT01858259 ·Status: UNKNOWN
-
Making it Work Program for Systemic Sclerosis
NCT06338722 ·Status: COMPLETED ·Phase: NA
-
Injection of Autologous Adipose-derived Stromal Vascular Fraction in the Finger of Systemic Sclerosis Patients
NCT03060551 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
A Non-Interventional Pilot Study Assessing Whether Lysyl Oxidase-like 2 (LOXL2) is Present in Subjects With Scleroderma
NCT01881529 ·Status: COMPLETED
-
EFFECTS OF THE MICRO REINJECTION OF AUTOLOGOUS ADIPOSE TISSUE IN THE FACE OF PATIENTS WITH SYSTEMIC SCLEROSIS
NCT02206672 ·Status: UNKNOWN ·Phase: NA